Description
The DoW Rare Cancers Concept Award supports highly innovative, untested, potentially groundbreaking novel concepts in rare cancers. The award mechanism allows PIs to pursue serendipitous observations and high-risk studies that have the potential to reveal entirely new avenues for investigation. Applications must describe how the new idea will enhance the existing knowledge of rare cancers or develop an innovative and novel course of investigation. The program announcement includes a two-step application process, with a pre-application submission and a full application submission. The award has a maximum period of performance of 2 years and a cost cap of $140,000. The CDMRP expects to allot roughly $2.52M to fund approximately 18 Concept Award applications.
• The program announcement includes a two-step application process, with a pre-application submission and a full application submission.
• The award has a maximum period of performance of 2 years and a cost cap of $140,000.
• The CDMRP expects to allot roughly $2.52M to fund approximately 18 Concept Award applications.
• The program announcement includes a list of focus areas, including biology, preclinical research model, therapy, and artificial intelligence and machine learning model.
• The award mechanism supports high-risk studies that have the potential to reveal entirely new avenues for investigation.